Marcus advises leading arrangers and managers in connection with European CLOs for both private lending warehouse and public take-out stages. He also has experience in asset-backed leveraged (ABL) facilities, collateralised fund obligations (CFOs) and other private structured lending facilities.
Before joining Orrick, Marcus was a CLO Research Analyst at Dealscribe, where he helped build out the firm’s initial database for CLO investors.
With a wealth of experience and a deep understanding of the technology and innovation market, Livia regularly advises early and late-stage companies on both single and multi-tranche investment rounds, secondaries, bridge financings, LBOs, buyouts and other types of exits, mergers, and corporate reorganisations. She has worked with international innovative companies from their inception and has also advised many of the key venture capital and private equity investors in the Italian and international markets.
Alongside her focus on technologies, she has acquired specific experience in the healthcare sector by working alongside one of the world-leading groups in the laboratory analysis sector, from its entry onto the national scene to the consolidation of its leadership position in Italy through M&A transactions.
Please read before sending e-mail.
Please do not include any confidential, secret or otherwise sensitive information concerning any potential or actual legal matter in this e-mail message. Unsolicited e-mails do not create an attorney-client relationship and confidential or secret information included in such e-mails cannot be protected from disclosure. Orrick does not have a duty or a legal obligation to keep confidential any information that you provide to us. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.
By clicking "OK" below, you understand and agree that Orrick will have no duty to keep confidential any information you provide.
